Contrast-enhanced MRI of murine myocardial infarction - Part II

NMR in Biomedicine

Volumn 25, Issue 8, 2012, Pages 969-984

  Coolen, Bram F ^a   Paulis, Leonie E M ^a   Geelen, Tessa ^a   Nicolay, Klaas ^a   Strijkers, Gustav J ^a  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Cardiovascular MR (CMR) methods; Heart function; Heart structure; Ischemic heart diseases; Myocardial perfusion; Myocardial viability

Indexed keywords

CARDIOVASCULAR MR (CMR) METHODS; HEART FUNCTION; ISCHEMIC HEART DISEASE; MYOCARDIAL PERFUSION; MYOCARDIAL VIABILITY;

HEART; MAGNETIC RESONANCE IMAGING; TISSUE;

MAMMALS;

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTRAST SENSITIVITY; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; EXPERIMENTAL MODEL; HEART CYCLE; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART RATE; IMAGE QUALITY; MOUSE; NONHUMAN; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; REVIEW; SIGNAL NOISE RATIO;

ANIMALS; CONTRAST MEDIA; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MICE; MYOCARDIAL INFARCTION; MYOCARDIUM; PERFUSION;

MURINAE; MUS;

EID: 84863780401     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2767     Document Type: Review

References (117)

1. Epstein FH. MR in mouse models of cardiac disease. NMR Biomed. 2007; 20: 238-255.
2. Bremerich J, Wendland MF, Arheden H, Wyttenbach R, Gao DW, Huberty JP, Dae MW, Higgins CB, Saeed H. Microvascular injury in reperfused infarcted myocardium: Noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging. J. Am. Coll. Cardiol. 1998; 32: 787-793.
3. 1 mapping manganese-enhanced magnetic resonance imaging. Magn. Reson. Med. 2011; 65: 239-249.
4. Yang ZQ, Berr SS, Gilson WD, Toufektsian MC, French BA. Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction. Circulation 2004; 109: 1161-1167.
5. Sosnovik DE, Garanger E, Aikawa E, Nahrendorf M, Figuiredo JL, Dai GP, Reynolds F, Rosenzweig A, Weissleder R, Josephson L. Molecular MRI of cardiomyocyte apoptosis with simultaneous delayed-enhancement MRI distinguishes apoptotic and necrotic myocytes in vivo potential for midmyocardial salvage in acute ischemia. Circ. Cardiovasc. Imaging 2009; 2: 460-467.
6. Yang YD, Yang YH, Yanasak N, Schumacher A, Hu TCC. Temporal and noninvasive monitoring of inflammatory-cell infiltration to myocardial infarction sites using micrometer-sized iron oxide particles. Magn. Reson. Med. 2010; 63: 33-40.
7. Appleton GO, Li Y, Taffet GE, Hartley CJ, Michael LH, Entman ML, Roberts R, Khoury DS. Determinants of cardiac electrophysiological properties in mice. J. Interv. Card. Electr. 2004; 11: 5-14.
8. Kober F, Iltis I, Cozzone PJ, Bernard M. Myocardial blood flow mapping in mice using high-resolution spin labeling magnetic resonance imaging: influence of ketamine/xylazine and isoflurane anesthesia. Magn. Reson. Med. 2005; 53: 601-606.
9. Caravan P, Das B, Dumas S, Epstein FH, Helm PA, Jacques V, Koerner S, Kolodziej A, Shen L, Sun WC, Zhang Z. Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. Angew. Chem. Int. Ed. Engl. 2007; 46: 8171-8173.
10. Bohl S, Lygate C, Barnes H, Medway D, Stork L, Schulz-Menger J, Neubauer S, Schneider JE. Advanced methods for quantification of infarct size in mice using three-dimensional high-field late gadolinium enhancement MRI. Am. J. Physiol. Heart Circ. Physiol. 2009; 296: 1200-1208.
11. Cassidy PJ, Schneider JE, Grieve SM, Lygate C, Neubauer S, Clarke K. Assessment of motion gating strategies for mouse magnetic resonance at high magnetic fields. J. Magn. Reson. Imaging 2004; 19: 229-237.
12. Protti A, Sirker A, Shah AM, Botnar R. Late gadolinium enhancement of acute myocardial infarction in mice at 7T: cine FLASH versus inversion recovery. J. Magn. Reson. Imaging 2010; 32: 878-886.
13. Feintuch A, Zhu YH, Bishop J, Davidson L, Dazai J, Bruneau BG, Henkelman RM. 4D cardiac MRI in the mouse. NMR Biomed. 2007; 20: 360-365.
14. Bishop J, Feintuch A, Bock NA, Nieman B, Dazai J, Davidson L, Henkelman RM. Retrospective gating for mouse cardiac MRI. Magn. Reson. Med. 2006; 55: 472-477.
15. Heijman E, de Graaf WL, Niessen P, Nauerth A, van Eys G, de Graaf L, Nicolay K, Strijkers GJ. Comparison between prospective and retrospective triggering for mouse cardiac MRI. NMR Biomed. 2007; 20: 439-447.
16. Nieman BJ, Szulc KU, Turnbull DH. Three-dimensional in vivo MRI with self-gating and image coregistration in the mouse. Magn. Reson. Med. 2009; 61: 1148-1157.
17. Hiba B, Richard N, Janier M, Croisille P. Cardiac and respiratory double self-gated cine MRI in the mouse at 7T. Magn. Reson. Med. 2006; 55: 506-513.
18. Esparza-Coss E, Ramirez MS, Bankson JA. Wireless self-gated multiple-mouse cardiac cine MRI. Magn. Reson. Med. 2008; 59: 1203-1206.
19. Bovens SM, Boekhorst B, den Ouden K, van de Kolk KWA, Nauerth A, Nederhoff MGJ, Pasterkamp G, ten Hove M, van Echteld CJA. Evaluation of infarcted murine heart function: comparison of prospectively triggered with self-gated MRI. NMR Biomed. 2011; 24: 307-315.
20. 1 mapping cardiac manganese-enhanced MRI in a murine myocardial infarction model. NMR Biomed. 2008; 21: 1102-1111.
21. Bucholz E, Ghaghada K, Qi Y, Mukunadan S, Johnson GA. Four-dimensional MR microscopy of the mouse heart using radial acquisition and liposomal gadolinium contrast agent. Magn. Reson. Med. 2008; 60: 111-118.
22. Coolen BF, Moonen RPM, Paulis LEM, Geelen T, Nicolay K, Strijkers GJ. Mouse myocardial first-pass perfusion MR imaging. Magn. Reson. Med. 2010; 64: 1658-1663.
23. Schneider JE, Wiesmann F, Lygate CA, Neubauer S. How to perform an accurate assessment of cardiac function in mice using high-resolution magnetic resonance imaging. J. Cardiovasc. Magn. Reson. 2006; 8: 693-701.
24. 1 mapping of the mouse heart using variable flip angle steady-state MR imaging. NMR Biomed. 2010; 24: 154-162.
25. Larkman DJ, Nunes RG. Parallel magnetic resonance imaging. Phys. Med. Biol. 2007; 52: R15-R55.
26. Ratering D, Baltes C, Dorries C, Rudin M. Accelerated cardiovascular magnetic resonance of the mouse heart using self-gated parallel imaging strategies does not compromise accuracy of structural and functional measures. J. Cardiovasc. Magn. Reson. 2010; 12: 43.
27. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn. Reson. Med. 1999; 42: 952-962.
28. Schneider JE, Lanz T, Barnes H, Stork L, Bohl S, Lygate C, Ordidge RJ, Neubauer S. Accelerated cardiac magnetic resonance imaging in the mouse using an eight-channel array at 9.4 Tesla. Magn. Reson. Med. 2011; 65: 60-70.
29. Blaimer M, Breuer FA, Mueller M, Seiberlich N, Ebel D, Heidemann RM, Griswold MA, Jakob PM. 2D-GRAPPA-operator for faster 3D parallel MRI. Magn. Reson. Med. 2006; 56: 1359-1364.
30. Griswold MA, Jakob PM, Heidemann RM, Nittka M, Jellus V, Wang JM, Kiefer B, Haase A. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn. Reson. Med. 2002; 47: 1202-1210.
31. Croisille P, Revel D, Saeed M. Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside. Eur. Radiol. 2006; 16: 1951-1963.
32. Kim RJ, Chen EL, Lima JAC, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996; 94: 3318-3326.
33. Kim RJ, Albert TSE, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction - An international, multicenter, double-blinded, randomized trial. Circulation 2008; 117: 629-637.
34. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218: 215-223.
35. Helm PA, Caravan P, French BA, Jacques V, Shen LH, Xu YQ, Beyers RJ, Roy RJ, Kramer CM, Epstein FH. Postinfarction myocardial scarring in mice: Molecular MR imaging with use of a collagen-targeting contrast agent. Radiology 2008; 247: 788-796.
36. Gilson WD, Kraitchman DL. Cardiac magnetic resonance imaging in small rodents using clinical 1.5T and 3.0T scanners. Methods 2007; 43: 35-45.
37. Bohl S, Medway DJ, Schulz-Menger J, Schneider JE, Neubauer S, Lygate CA. Refined approach for quantification of in vivo ischemia-reperfusion injury in the mouse heart. Am. J. Physiol. Heart Circ. Physiol. 2009; 297: H2054-H2058.
38. Chapon C, Herlihy AH, Bhakoo KK. Assessment of myocardial infarction in mice by late gadolinium enhancement MR imaging using an inversion recovery pulse sequence at 9.4T. J. Cardiovasc. Magn. Reson. 2008; 10: 6.
39. Nahrendorf M, Sosnovik D, Chen JW, Panizzi P, Figueiredo JL, Aikawa E, Libby P, Swirski FK, Weissleder R. Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. Circulation 2008; 117: 1153-1160.
40. Geelen T, Paulis LEM, Coolen BF, Nicolay K, Strijkers GJ. Passive targeting of paramagnetic lipid-based contrast agents to acute mouse cardiac ischemia/reperfusion injury. Proceedings of the 19th Annual Meeting ISMRM, Montreal, Canada, 2011; 1356.
41. Paulis LEM, Geelen T, Kuhlmann M, Coolen BF, Nicolay K, Strijkers GJ. Contrast-enhanced cardiac MRI of vascular remodeling after myocardial infarction using lipid-based nanoparticles. Proceedings of the 19th Annual Meeting ISMRM, Montreal, Canada, 2011; 1358.
42. Spuentrup E, Ruhl KM, Botnar RM, Wiethoff AJ, Buhl A, Jacques V, Greenfield MT, Krombach GA, Gunther RW, Vangel MG, Caravan P. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent initial feasibility study in a swine model. Circulation 2009; 119: 1768-1775.
43. Naresh NK, Klibanov AL, Vandsburger MH, Leor J, Xu Y, French BA, Epstein FH Serial quantitative MRI of post-infarct macrophage infiltration of the mouse heart using Gd-liposomes and R1-mapping. Proceedings of the 19th Annual Meeting ISMRM, Montreal, Canada, 2011; 1355.
44. Huang S, Chen HH, Yuan H, Dai G, Schule D, Ngoy S, Liao R, Caravan P, Josephson L, Sosnovik D. Molecular MRI of acute necrosis with a novel DNA-binding gadolinium chelate: kinetics of cell death and clearance in infarcted myocardium. J. Cardiovasc. Magn. Reson. 2011; 13(Suppl I): O23.
45. 1 mapping. Magn. Reson. Med. 2006; 55: 604-611.
46. Vandsburger MH, Epstein FH. Emerging MRI methods in translational cardiovascular research. J. Cardiovasc. Trans. Res. 2011; DOI 10.1007/s12265-12011-19275-12261
47. 1 mapping: application to patients with acute and chronic myocardial infarction. Magn. Reson. Med. 2007; 58: 34-40.
48. 1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study. Am. J. Roentgenol. 2006; 187: W630-W635.
49. Campbell AE, Price AN, Ellmerich S, Simons P, Al-Shawi R, Hawkins PN, Ordidge RJ, Pepys MB, Moon JC, Lythgoe MF. Equilibrium contrast CMR or the detection of amyloidosis in mice. J. Cardiovasc. Magn. Reson. 2011; 13(Suppl1): O60.
50. Vandsburger MH, Janiczek RL, Xu YQ, French BA, Meyer CH, Kramer CM, Epstein FH. Improved arterial spin labeling after myocardial infarction in mice using cardiac and respiratory gated look-locker imaging with fuzzy c-means clustering. Magn. Reson. Med. 2010; 63: 648-657.
51. 1 values by snapshot-FLASH NMR imaging. J. Magn. Reson. 1992; 96: 608-612.
52. 1 mapping of the heart. Magn. Reson. Med. 2004; 52: 141-146.
53. Schneider JE, Cassidy PJ, Lygate C, Tyler DJ, Wiesmann F, Grieve SM, Hulbert K, Clarke K, Neubauer S. Fast, high-resolution in vivo cine magnetic resonance imaging in normal and failing mouse hearts on a vertical 11.7T system. J. Magn. Reson. Imaging 2003; 18: 691-701.
54. Vandsburger MH, French BA, Helm PA, Roy RJ, Kramer CM, Young AA, Epstein FH. Multi-parameter in vivo cardiac magnetic resonance imaging demonstrates normal perfusion reserve despite severely attenuated beta-adrenergic functional response in neuronal nitric oxide synthase knockout mice. Eur. Heart J. 2007; 28: 2792-2798.
55. Streif JUG, Nahrendorf M, Hiller KH, Waller C, Wiesmann F, Rommel E, Haase A, Bauer WR. In vivo assessment of absolute perfusion and intracapillary blood volume in the murine myocardium by spin labeling magnetic resonance imaging. Magn. Reson. Med. 2005; 53: 584-592.
56. 1 mapping of mouse myocardium with saturation recovery Look-Locker method. Magn. Reson. Med. 2010; 64: 1296-1303.
57. 2 mapping using gradient recalled acquisition in the steady state. Magn. Reson. Med. 2003; 49: 515-526.
58. Bluml S, Schad LR, Stepanow B, Lorenz WJ. Spin-lattice relaxation time measurement by means of a turboFLASH technique. Magn. Reson. Med. 1993; 30: 289-295.
59. 1 with high-speed incorporation of RF field inhomogeneities (DESPOT1-HIFI). J. Magn. Reson. Imaging 2007; 26: 1106-1111.
60. Coolen BF, Geelen T, Paulis LEM, Nicolay K, Strijkers GJ. Regional contrast agent quantification in a mouse model of myocardial infarction using 3D cardiac T1 mapping. J. Cardiovasc. Magn. Reson. 2011; 13: 56.
61. Sosnovik DE, Nahrendorf M, Deliolanis N, Novikov M, Aikawa E, Josephson L, Rosenzweig A, Weissleder R, Ntziachristos V. Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation 2007; 115: 1384-1391.
62. Heyn C, Bowen CV, Rutt BK, Foster PJ. Detection threshold of single SPIO-labeled cells with FIESTA. Magn. Reson. Med. 2005; 53: 312-320.
63. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP. MRI detection of single particles for cellular imaging. P. Natl Acad. Sci. USA. 2004; 101: 10901-10906.
64. Heiland S. From A as in aliasing to Z as in zipper: artifacts in MRI. Clin. Neuroradiol. 2008; 18: 25-36.
65. Sosnovik DE, Schellenberger EA, Nahrendorf M, Novikov MS, Matsui T, Dai G, Reynolds F, Grazette L, Rosenzweig A, Weissleder R, Josephson L. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn. Reson. Med. 2005; 54: 718-724.
66. Sosnovik DE, Nahrendorf M, Panizzi P, Matsui T, Aikawa E, Dai GP, Li L, Reynolds F, Dorn GW, Weissleder R, Josephson L, Rosenzweig A. Molecular MRI detects low levels of cardiomyocyte apoptosis in a transgenic model of chronic heart failure. Circ. Cardiovasc. Imaging 2009; 2: 468-475.
67. 2* changes in mouse myocardium following ischemia-reperfusion injury. Proceedings of the 19th Annual Meeting ISMRM, Montreal, Canada, 2011; 1363.
68. 2-weighted MRI of post--infarct myocardial edema in mice. Magn. Reson. Med. 2011; DOI 10.1002/mrm.22975
69. 2 quantification for improved detection of myocardial edema. J. Cardiovasc. Magn. Reson. 2009; 11: 56.
70. 2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction. Invest. Radiol. 2008; 43: 7-15.
71. 2 mapping of the mouse heart using segmented MLEV supercycle preparation. Proceedings of the 19th Annual Meeting ISMRM, Montreal, Canada, 2010; 1367.
72. 2-mapping of ischemia-reperfusion injury in the in vivo mouse heart. J. Cardiovasc. Magn. Reson. 2010; 12(Suppl I): O61.
73. van den Bos EJ, Baks T, Moelker AD, Kerver W, van Geuns RJ, van der Giessen WJ, Duncker DJ, Wielopolski PA. Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts: possible interference with iron oxide-labelled cell tracking? Eur. Heart J. 2006; 27: 1620-1626.
74. Liu W, Dahnke H, Jordan EK, Schaeffter T, Frank JA. In vivo MRI using positive-contrast techniques in detection of cells labeled with superparamagnetic iron oxide nanoparticles. NMR Biomed. 2008; 21: 242-250.
75. Robson MD, Gatehouse PD, Bydder M, Bydder GM. Magnetic resonance: an introduction to ultrashort TE (UTE) imaging. J. Comput. Assist. Tomo. 2003; 27: 825-846.
76. Dahnke H, Liu W, Herzka D, Frank JA, Schaeffter T. Susceptibility gradient mapping (SGM): a new postprocessing method for positive contrast generation applied to superparamagnetic iron oxide particle (SPIO)-labeled cells. Magn. Reson. Med. 2008; 60: 595-603.
77. Stuber M, Gilson WD, Schar M, Kedziorek DA, Hofmann LV, Shah S, Vonken EJ, Bulte JWM, Kraitchman DL. Positive contrast visualization of iron oxide-labeled stem cells using Inversion-Recovery with ON-resonant water suppression (IRON). Magn. Reson. Med. 2007; 58: 1072-1077.
78. Mani V, Briley-Saebo KC, Itskovich VV, Samber DD, Fayad ZA Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn. Reson. Med. 2006; 55: 126-135.
79. Seppenwoolde JH, Viergever MA, Bakker CJG. Passive tracking exploiting local signal conservation: the white marker phenomenon. Magn. Reson. Med. 2003; 50: 784-790.
80. Idiyatullin D, Corum C, Park JY, Garwood M. Fast and quiet MRI using a swept radiofrequency. J. Magn. Reson. 2006; 181: 342-349.
81. Mani V, Adler E, Briley-Saebo KC, Bystrup A, Fuster V, Keller G, Fayad ZA. Serial in vivo positive contrast MRI of iron oxide-labeled embryonic stem cell-derived cardiac precursor cells in a mouse model of myocardial infarction. Magn. Reson. Med. 2008; 60: 73-81.
82. Farrar CT, Dai GP, Novikov M, Rosenzweig A, Weissleder R, Rosen BR, Sosnovik DE. Impact of field strength and iron oxide nanoparticle concentration on the linearity and diagnostic accuracy of off-resonance imaging. NMR Biomed. 2008; 21: 453-463.
83. Zhou R, Idiyatullin D, Moeller S, Corum C, Zhang HL, Qiao H, Zhong J, Garwood M. SWIFT detection of SPIO-labeled stem cells grafted in the myocardium. Magn. Reson. Med. 2010; 63: 1154-1161.
84. Salerno M, Epstein FH, Kramer CM. MADE: a dark-blood delayed enhancement sequence to improve detection of subendocardial infarcts (motion attenuated delayed enhancement). Proceedings of the 17th Annual Meeting of ISMRM, Honolulu, Hawaii, USA, 2009; 3914.
85. 2-weighted MRI. Proceedings of the 19th Annual Meeting ISMRM, Montreal, Canada, 2011; 3408.
86. Lefrancois W, Miraux S, Calmettes G, Pourtau L, Franconi F, Diolez P, Thiaudiere E. A fast black-blood sequence for four-dimensional cardiac manganese-enhanced MRI in mouse. NMR Biomed. 2011; 24: 291-298.
87. Berr SS, Roy RJ, French BA, Yang ZQ, Gilson W, Kramer CM, Epstein FH. Black blood gradient echo cine magnetic resonance imaging of the mouse heart. Magn. Reson. Med. 2005; 53: 1074-1079.
88. Giang TH, Nanz D, Coulden R, Friedrich M, Graves M, Al-Saadi N, Luscher TF, von Schulthess GK, Schwitter J. Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur. Heart J. 2004; 25: 1657-1665.
89. Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, Fleck E. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 2003; 108: 432-437.
90. Stuckey DJ, Carr CA, Meader SJ, Tyler DJ, Cole MA, Clarke K. First-pass perfusion CMR two days after infarction predicts severity of functional impairment six weeks later in the rat heart. J. Cardiovasc. Magn. Reson. 2011; 13: 38.
91. Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L, Kraitchman DL Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J. Cardiovasc. Magn. Reson. 2008; 10: 18.
92. Antkowiak PF, Janiczek RL, Gibberman LB, Xu C, Kramer CM, Meyer CH, French BA, Epstein FH Quantitative first-pass perfusion MRI of the mouse heart. J. Cardiovasc. Magn. Reson. 2010; 12(Suppl I): M10.
93. Makowski M, Jansen C, Webb I, Chiribiri A, Nagel E, Botnar R, Kozerke S, Plein S. First-pass contrast-enhanced myocardial perfusion MRI in mice on a 3T clinical MR scanner. Magn. Reson. Med. 2010; 64: 1592-1598.
94. Pedersen H, Kozerke S, Ringgaard S, Nehrke K, Kim WY. k-t PCA: temporally constrained k-t BLAST reconstruction using principal component analysis. Magn. Reson. Med. 2009; 62: 706-716.
95. Jerosch-Herold M. Quantification of myocardial perfusion by cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 2010; 12: 57.
96. Kostler H, Ritter C, Lipp M, Beer M, Hahn D, Sandstede J. Prebolus quantitative MR heart perfusion imaging. Magn. Reson. Med. 2004; 52: 296-299.
97. Wech T, Lemke A, Medway D, Stork L, Lygate C, Neubauer S, Kostler H, Schneider JE. Accelerating cine-MR imaging in mouse hearts using compressed sensing. J. Magn. Reson. Imaging 2011; 34: 1072-1079.
98. Ambrosio G, Tritto I. Reperfusion injury: Experimental evidence and clinical implications. Am. Heart J. 1999; 138: S69-S75.
99. Wiesmann F, Ruff J, Engelhardt S, Hein L, Dienesch C, Leupold A, Illinger R, Frydrychowicz A, Hiller KH, Rommel E, Haase A, Lohse MJ, Neubauer S. Dobutamine-stress magnetic resonance microimaging in mice - acute changes of cardiac geometry and function in normal and failing murine hearts. Circ. Res. 2001; 88: 563-569.
100. 2 relaxivity. Magn. Reson. Med. 2009; 61: 1022-1032.
101. 1 relaxation model for intracellular paramagnetic contrast agents. Magn. Reson. Med. 2009; 61: 1049-1058.
102. Henkelman RM, Stanisz GJ, Graham SJ. Magnetization transfer in MRI: a review. NMR Biomed. 2001; 14: 57-64.
103. Weber OM, Speier P, Scheffler K, Bieri O. Assessment of magnetization transfer effects in myocardial tissue using balanced steady-state free precession (bSSFP) CINE MRI. Magn. Reson. Med. 2009; 62: 699-705.
104. Miraux S, Calmettes G, Massot P, Lefrancois W, Parzy E, Muller B, Arscac LM, Deschodt-Arsac V, Franconi J, Diolez P, Thiaudiere E. 4D retrospective black blood TrueFISP imaging of the mouse heart. Magn. Reson. Med. 2009; 62: 1099-1105.
105. Weiss CR, Aletras AH, London JF, Taylor JL, Epstein FH, Wassmuth R, Balaban RS, Arai AE. Stunned, infarcted, and normal myocardium in dogs: simultaneous differentiation by using gadolinium-enhanced CINE MR imaging with magnetization transfer contrast. Radiology 2003; 226: 723-730.
106. Jacquier A, Kober F, Sotsikhikun B, Roch G, Cozzone PJ, Bernard M. Quantification of myocardial blood flow and flow reserve in rats using arterial spin labeling MRI: comparison with a fluorescent microsphere technique. NMR Biomed. 2011; 24(9): 1047-1053.
107. de Jong S, Zwanenburg JJ, Visser F, der Nagel R, van Rijen HV, Vos MA, de Bakker JM, Luijten PR. Direct detection of myocardial fibrosis by MRI. J. Mol. Cell. Cardiol. 2011; 51(6): 974-979.
108. Basser PJ, Pajevic S, Pierpaoli C, Duda J, Aldroubi A. In vivo fiber tractography using DT-MRI data. Magn. Reson. Med. 2000; 44: 625-632.
109. Huang S, Dai G, Sosnovik DE Diffusion weighted MRI of the mouse heart in vivo following ischemia/reperfusion injury. Proceedings of the 18th Annual Meeting ISMRM, Stockholm, Sweden, 2010; 488.
110. uang S, Mekkaoui C, Che HH, Ngoy S, Bauer M, Wang R, Wedeen VJ, Dai GE, Liao R, Sosnovik D. Microstructural signatures of ischemia and stem cell therapy in the myocardium revealed with serial diffusion tensor MRI and tractography of the mouse heart in vivo. Proceedings of the 19th Annual Meeting ISMRM, Montreal, Canada, 2011; 18.
111. Chacko VP, Aresta F, Chacko SM, Weiss RG MRI/MRS assessment of in vivo murine cardiac metabolism, morphology, and function at physiological heart rates. Am. J. Physiol. Heart Circ. Physiol. 2000; 279: H2218-H2224.
112. 1H-MRS in the mouse. Magn. Reson. Med. 2004; 52: 1029-1035.
113. ten Hove M, Neubauer S. MR spectroscopy in heart failure - clinical and experimental findings. Heart Fail. Rev. 2007; 12: 48-57.
114. 23Na microscopy of the mouse heart in vivo using density-weighted chemical shift imaging. Magn. Reson. Mater. Phys. 2004; 17: 196-200.
115. Tyler DJ, Schroeder MA, Cochlin LE, Clarke K, Radda GK. Application of hyperpolarized magnetic resonance in the study of cardiac metabolism. Appl. Magn. Reson. 2008; 34: 523-531.
116. 13C imaging - a new diagnostic platform. Eur. Radiol. 2006; 16: 57-67.
117. Geelen T, Paulis LEM, Coolen BF, Nicolay K, Strijkers GJ. Contrast-enhanced MRI of murine myocardial infarction - Part I. NMR Biomed. 2012, DOI: 10.1002/nbm.2768.